Israeli AI Fertility Tool Integrated Into Medical Records At IVF Clinics

An Israeli artificial intelligence startup that helps women with in-vitro fertilization (IVF) cycles has integrated its technology into the electronic medical records (EMR) used by numerous fertility clinics around the world. 

Fairtility’s CHLOE (Cultivating Life Through Optimal Embryos) technology uses AI to assess the viability of a woman’s embryos throughout her IVF cycle, a medical procedure in which the egg is fertilized outside of the body.

By integrating CHLOE with their EMRs, clinicians can digitize their embryology labs, automatically capturing and processing data regarding the most viable embryos for implantation.

CHLOE will then generate an embryo quality score and implantation predictions with insights and explanations based on millions of data points, which may improve IVF outcomes for patients –  a treatment that is normally only successful in one out of three tries.

The company says that integrating CHLOE into their systems helps reduce the administrative work of embryologists by up to 30 percent, as it also ensures that they have all their key information in one place.

The EMR platforms that have integrated CHLOE include vRepro, IDEAS from Mellowood Medical, nAble IVF and MedITEX.

“Integrating Fairtility’s CHLOE with the top EMR platforms enables clinics to seamlessly consolidate and standardize all data from both clinical and operational sources, moving us towards digital transformation of reproductive care,” said Eran Eshed, CEO and co-founder of Fairtility.

“These integrations enable information to flow seamlessly, maximizing clinic and lab efficiency and transforming both the patient and clinician experience.”